(Total Views: 524)
Posted On: 11/21/2023 1:28:23 PM
Post# of 154723
sean007,
The link below will bring up HHI Gambler's post of Dr. Lalezari's 12/8/21 email to colleagues at the FDA and various colleges about Leronlimab. I suspect everyone has read it, but I think it is worth reviewing in view of Dr. L's new position with the company. I think you are correct when you said he talked about mismanagement, but I could not find that one.
https://investorshangout.com/post/view?id=6298450
Here is a link to a good article Drs. Lalezari and Seethamraju wrote on 5/7/21 about the benefit of Leronlimab for critically ill Covid patients.
https://www.counterpunch.org/2021/05/07/hope-...hin-reach/
The link below will bring up HHI Gambler's post of Dr. Lalezari's 12/8/21 email to colleagues at the FDA and various colleges about Leronlimab. I suspect everyone has read it, but I think it is worth reviewing in view of Dr. L's new position with the company. I think you are correct when you said he talked about mismanagement, but I could not find that one.
https://investorshangout.com/post/view?id=6298450
Here is a link to a good article Drs. Lalezari and Seethamraju wrote on 5/7/21 about the benefit of Leronlimab for critically ill Covid patients.
https://www.counterpunch.org/2021/05/07/hope-...hin-reach/
(9)
(0)
